Skip to content

Comparison of the analgesic effect of ultrasound-guided liposome bupivacaine for quadratus lumborum block at the lateral supra-arcuate ligament with anterior quadratus lumbosum block after lower section cesarean section

Comparison of the analgesic effect of ultrasound-guided liposome bupivacaine for quadratus lumborum block at the lateral supra-arcuate ligament with anterior quadratus lumbosum block after lower section cesarean section

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500102081
Enrollment
Unknown
Registered
2025-05-08
Start date
2025-06-01
Completion date
Unknown
Last updated
2025-05-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain after cesarean section

Interventions

Ultrasound guided bilateral LB-AQLB group (group A):After surgery, ultrasound guided bilateral LB-AQLB was performed by an experienced anesthesiologist
LB-QLB-LSAL group (group L):After surgery, ultrasound guided bilateral LB-QLB-LSAL was performed by an experienced anesthesiologist

Sponsors

Anhui Women and Children Medical Center
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 36 Years

Inclusion criteria

Inclusion criteria: (1) term 37-41 gestational weeks (2) singleton pregnancy (3) age 20-36 years old (4) BMI 21.0-35.0 kg/m^2 (5) ASA grade II or III

Exclusion criteria

Exclusion criteria: (1) any related major cardiac or respiratory disease, hematological system disease or coagulation parameter disorder, pre-existing vital organ dysfunction (such as liver and kidney failure). (2) contraindications of neuraxial anesthesia and nerve block. (3) severe pregnancy complications (high-risk pregnancy such as severe preeclampsia, placental abruption and complete placenta previa). (4) known fetal abnormalities. (5) history of chronic pain. (6) patients with mental disorders or inability to understand NRS scores. (7) patients allergic to opioid or liposomal bupivacaine. (8) patients who refused to participate in the study.

Design outcomes

Primary

MeasureTime frame
Opioid consumption;

Secondary

MeasureTime frame
0-72 h pain Numerical rating scale (NRS) area under curve (AUC);NRS after surgery;MAP and HR were measured after surgery;Patient comfort score (BCS);Quality of recovery score (QoR-15 scale);Plasma interleukin-6 (IL-6) levels;Tumor necrosis factor-a (TNF-a) levels;

Countries

China

Contacts

Public ContactTianzhen Ji

Anhui Women and Children Medical Center

happy_tianzhen@126.com+86 152 5655 0911

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026